Navigation Links
Fewer adverse cardiac events at one year
Date:10/23/2007

WASHINGTON, DC OCTOBER 22, 2007 Late breaking results from the SPIRIT III trial, presented at TCT 2007, the annual scientific symposium of the Cardiovascular Research Foundation, show that after 12 months, there were significantly fewer major adverse cardiac events (MACE) such as heart attacks, deaths from cardiac causes or repeat procedures (angioplasty or surgery) to clear the original vessel blockage after using a Xience V everolimus-eluting coronary stent than a Taxus paclitaxel-eluting stent.

The rate of the primary endpoint, in-segment late loss (a measure of how much the artery re-narrows following stenting) was also reduced by 50% with the Xience V stent compared to Taxus. There were no significant differences in other secondary endpoints between the two stent types, including target vessel failure (a combination of repeat procedures anywhere in the involved blood vessel and adverse cardiac events), as well as stent thrombosis (dangerous blood clots that can form within the stent).

Both the primary endpoint of the trial and the major secondary endpoint were met, said Gregg W. Stone, MD, Chairman, Cardiovascular Research Foundation and Professor of Medicine, Columbia University Medical Center. Moreover, the reduction in major adverse cardiac events with the Xience V stent compared to the Taxus stent is an important finding that signifies improved long-term outcomes for patients with heart disease. Given this positive finding, which has never before been seen in a pivotal drug-eluting stent vs. stent trial, coupled with the ease of use of Xience, will result in this device becoming a favored drug-eluting stent for clinicians treating coronary disease.

Further studies are required to determine whether there are meaningful differences between the two stent types in low frequency safety events, and in important subgroups, Stone added.

SPIRIT III 12-Month Results

Everolimus-Eluting Stent Paclitaxel-Elu
'/>"/>

Contact: Irma Damhuis
idamhuis@crf.org
917-558-5180
Cardiovascular Research Foundation
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Chemotherapy Pill Has Fewer Side Effects Than IV
2. Fewer teeth & Increased Ischemic Stroke risk
3. Heart Patients More At Risk Get Fewer Medicines
4. Fewer People Die Due To Cancer
5. Fewer Breast Cancer Patients to Get Chemo
6. Fewer Blacks Undergo Lung Cancer Surgery
7. Thailand had Fewer AIDS-Related Deaths, New HIV Cases In 2005
8. Fewer Neurons in Amygdala of Autistic Males
9. Women With Fewer Periods Have Low Risk Of Gynecological Cancer
10. Fewer Doctors Treating For Free
11. Fruits & Vegetables Makes You Look Younger With Fewer Wrinkles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... 2014 Dr. Paul Vitenas, one of the ... & Glow Holiday Event for those in the area that would ... practice. Glitter & Glow will take place on December 11, 2014, ... in the heart of Houston at 4208 Richmond Ave. , ... that you will come and celebrate the season with us on ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Secura ... the few insurance marketing organizations in the country ... and asset protection marketplace. Secura Consultants is proud ... with Principal Financial Group, a leading global financial ... ownership interests. With the ownership interest comes the ...
(Date:11/28/2014)... 2014 (HealthDay News) -- Celebration can quickly turn ... Thanksgiving Day, experts say. Over the last decade, ... occurred while people were using turkey fryers, according to ... actually cared for a patient who tried to deep ... done in any circumstances," Dr. Arthur Sanford, a burn ...
(Date:11/28/2014)... Kramer HealthDay Reporter , THURSDAY, ... the kitchen, through cooking classes or at home, may make ... recent review. Cooking programs and classes for children seem ... the new research. And, although the review didn,t look at ... programs might help children develop long-lasting healthy habits. ...
(Date:11/28/2014)... November 28, 2014 PreDiabetes ... and treatment, helped employees learn their risk for ... blood screening at a local school in partnership ... Work initiative. , As the Presenting Sponsor ... , PreDiabetes Centers is co-hosting diabetes-prevention presentations at ...
Breaking Medicine News(10 mins):Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 3Health News:Secura Consultants Offers Complimentary Buy-Sell Agreement Reviews 2Health News:Turkey Fryer Mishaps Can Cause Serious Burns 2Health News:Want Kids to Eat Better? Get Them Cooking 2Health News:Want Kids to Eat Better? Get Them Cooking 3Health News:PreDiabetes Centers Offers Workplace Diabetes Screening at Local School 2
... Study finds mortality and survival rates equal for both ... Minimally-invasive laparoscopic surgery and open surgery for colon cancer ... from 12 international studies involving over 3,300 patients. ... afraid that laparoscopy might impair survival in colorectal cancer ...
... not establish safe-limit price as guide for avoiding exposure ... you bought from a hip young street artist may be ... skin. , A new report finds that many pairs of ... stores and artists contain nickel, which can cause dermatitis on ...
... Bed & Back; Merger Sets Up Healthy ... Owned Back Retail Chain, LORTON, Va., May 16 ... home and workplace back wellness created an,ergonomic revolution, has ... Back. Healthy Back,s 18 stores and ecommerce division,claimed 2007 ...
... readings, study says , , FRIDAY, May 16 (HealthDay News) -- ... hormone secreted by the parathyroid glands may increase the risk ... , The Dutch study, published in the May issue ... by researchers that vitamin D, depression and other psychiatric illnesses ...
... Month-long Campaign to Emphasize the Importance of Oral ... National dental insurer United,Concordia Dental is celebrating ... and the British Dental Health Foundation to,promote the ... May 18,this year,s event is launching in the ...
... clinical trial has found that the experimental targeted therapy ... metastatic kidney cancer whose disease had worsened on other ... MD, an attending physician at Memorial Sloan-Kettering Cancer Center ... at the annual meeting of the American Society for ...
Cached Medicine News:Health News:Outcomes Similar for Laparoscopic, Open Colon Cancer Surgeries 2Health News:Cheaper Earrings More Likely to Contain Nickel 2Health News:Cheaper Earrings More Likely to Contain Nickel 3Health News:The Back Wars Come to a Close 2Health News:Low Vitamin D Tied to Depression in Older Adults 2Health News:United Concordia Dental Celebrates National Smile Month 2Health News:Drug fends off kidney cancer progression 2
(Date:11/27/2014)... Nov. 27, 2014 - New ... Research - JIN Co., Ltd. will launch JINS ... price of 500,000 yen or $5,000 (without tax /including two ... "ACADEMIC PACK" is a dedicated solution of "JINS MEME" to ... analyze deep data* generated by electrooculography and six-axis sensors without ...
(Date:11/26/2014)... 26, 2014  Aethlon Medical, Inc. (OTCQB:AEMD), announced today ... raise approximately $3.3 million at a price of $0.30 ... healthcare focused investor. Each unit consists of one common ... purchase warrant. Each whole warrant entitles the holder to ... for a period of five years from closing.  ...
(Date:11/26/2014)... Nov. 26, 2014  Genomic Health, Inc. (Nasdaq: ... Chairman, Chief Executive Officer and President, will participate in ... at The New York Palace Hotel in ... 11:30 am Eastern Time (ET). To access ... call, go to the  Investor Relations  section of the ...
Breaking Medicine Technology:JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3
... a leading developer of innovative catheters and stents for ... closing of a $17M Round D financing.  The financing ... based EDB Investments (,EDBI,) with strong support from current ... are delighted to have Bio*One join our group of ...
... Arable Corporation ( www.arablecorp.com ) has announced the launch ... the clinical trial industry.  Whereas traditional CTMS systems have ... CTMS and EDC capabilities without the traditionally high start-up ... or CROs to manage the planning and implementation of ...
Cached Medicine Technology:TriReme Medical Announces $17 Million Series D Financing 2Arable Corporation Announces New Technology for Clinical Trial Industry 2
This table has adjustable height, an integral leg, and blade post. Includes a standard 2" (5 cm) pad....
... is designed for use without ... allowing for full C-Arm access. ... stored onboard when more stability ... quickly slide into standard sockets ...
... The onboard rail clamps ... O.R. tables and stretchers. ... any need for lifting. ... a stable surface combined ...
... The powered torso and ... Orthopedic Trauma Table simultaneously lift ... independent lift mechanism raises and ... for precise positioning. A wide ...
Medicine Products: